id	sid	tid	token	lemma	pos
ihlr-21707	1	1	microsoft	microsoft	PROPN
ihlr-21707	1	2	word	word	NOUN
ihlr-21707	1	3	final	final	ADJ
ihlr-21707	1	4	for	for	ADP
ihlr-21707	1	5	lulu	lulu	NOUN
ihlr-21707	1	6	vol	vol	NOUN
ihlr-21707	1	7	.	.	PUNCT
ihlr-21707	2	1	14	14	NUM
ihlr-21707	2	2	issue	issue	NOUN
ihlr-21707	2	3	1	1	NUM
ihlr-21707	2	4	final	final	ADJ
ihlr-21707	2	5	a.	a.	NOUN
ihlr-21707	2	6	the	the	DET
ihlr-21707	2	7	issue	issue	NOUN
ihlr-21707	2	8	:	:	PUNCT
ihlr-21707	2	9	increasing	increase	VERB
ihlr-21707	2	10	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	2	11	prices	price	NOUN
ihlr-21707	2	12	b.	b.	VERB
ihlr-21707	2	13	why	why	SCONJ
ihlr-21707	2	14	prescription	prescription	NOUN
ihlr-21707	2	15	affordability	affordability	NOUN
ihlr-21707	2	16	is	be	AUX
ihlr-21707	2	17	important	important	ADJ
ihlr-21707	2	18	c.	c.	NOUN
ihlr-21707	2	19	“	"	PUNCT
ihlr-21707	2	20	phrma	phrma	PROPN
ihlr-21707	2	21	’s	’s	PART
ihlr-21707	2	22	”	"	PUNCT
ihlr-21707	2	23	contributions	contribution	NOUN
ihlr-21707	2	24	to	to	ADP
ihlr-21707	2	25	the	the	DET
ihlr-21707	2	26	pricing	pricing	NOUN
ihlr-21707	2	27	problem	problem	NOUN
ihlr-21707	2	28	d.	d.	PROPN
ihlr-21707	2	29	general	general	PROPN
ihlr-21707	2	30	outline	outline	PROPN
ihlr-21707	2	31	a.	a.	NOUN
ihlr-21707	2	32	the	the	DET
ihlr-21707	2	33	legislation	legislation	NOUN
ihlr-21707	2	34	1	1	NUM
ihlr-21707	2	35	.	.	PUNCT
ihlr-21707	2	36	hatch	hatch	NOUN
ihlr-21707	2	37	-	-	PUNCT
ihlr-21707	2	38	waxman	waxman	PROPN
ihlr-21707	2	39	act	act	NOUN
ihlr-21707	2	40	2	2	NUM
ihlr-21707	2	41	.	.	PUNCT
ihlr-21707	2	42	patient	patient	ADJ
ihlr-21707	2	43	protection	protection	NOUN
ihlr-21707	2	44	and	and	CCONJ
ihlr-21707	2	45	affordable	affordable	ADJ
ihlr-21707	2	46	care	care	NOUN
ihlr-21707	2	47	act	act	NOUN
ihlr-21707	2	48	(	(	PUNCT
ihlr-21707	2	49	“	"	PUNCT
ihlr-21707	2	50	aca	aca	PROPN
ihlr-21707	2	51	”	"	PUNCT
ihlr-21707	2	52	)	)	PUNCT
ihlr-21707	2	53	(	(	PUNCT
ihlr-21707	2	54	“	"	PUNCT
ihlr-21707	2	55	obamacare	obamacare	PROPN
ihlr-21707	2	56	”	"	PUNCT
ihlr-21707	2	57	)	)	PUNCT
ihlr-21707	2	58	b.	b.	PROPN
ihlr-21707	3	1	the	the	DET
ihlr-21707	3	2	judiciary	judiciary	NOUN
ihlr-21707	3	3	(	(	PUNCT
ihlr-21707	3	4	ftc	ftc	PROPN
ihlr-21707	3	5	v.	v.	ADP
ihlr-21707	3	6	actavis	actavis	PROPN
ihlr-21707	3	7	)	)	PUNCT
ihlr-21707	3	8	a.	a.	NOUN
ihlr-21707	3	9	introduction	introduction	NOUN
ihlr-21707	3	10	b.	b.	PROPN
ihlr-21707	3	11	patent	patent	NOUN
ihlr-21707	3	12	and	and	CCONJ
ihlr-21707	3	13	antitrust	antitrust	ADJ
ihlr-21707	3	14	laws	law	NOUN
ihlr-21707	3	15	c.	c.	PROPN
ihlr-21707	3	16	generic	generic	ADJ
ihlr-21707	3	17	pharmaceutical	pharmaceutical	PROPN
ihlr-21707	3	18	company	company	NOUN
ihlr-21707	3	19	issues	issue	NOUN
ihlr-21707	3	20	d.	d.	PROPN
ihlr-21707	3	21	increased	increase	VERB
ihlr-21707	3	22	marketing	marketing	NOUN
ihlr-21707	3	23	expenditures	expenditure	NOUN
ihlr-21707	3	24	1	1	NUM
ihlr-21707	3	25	.	.	PUNCT
ihlr-21707	3	26	detailing	detail	VERB
ihlr-21707	3	27	e.	e.	PROPN
ihlr-21707	3	28	increasing	increase	VERB
ihlr-21707	3	29	costs	cost	NOUN
ihlr-21707	3	30	of	of	ADP
ihlr-21707	3	31	research	research	NOUN
ihlr-21707	3	32	&	&	CCONJ
ihlr-21707	3	33	development	development	PROPN
ihlr-21707	3	34	f.	f.	PROPN
ihlr-21707	3	35	increased	increase	VERB
ihlr-21707	3	36	medicare	medicare	PROPN
ihlr-21707	3	37	coverage	coverage	PROPN
ihlr-21707	3	38	a.	a.	PROPN
ihlr-21707	3	39	off	off	ADP
ihlr-21707	3	40	-	-	PUNCT
ihlr-21707	3	41	label	label	NOUN
ihlr-21707	3	42	prescription	prescription	NOUN
ihlr-21707	3	43	drug	drug	NOUN
ihlr-21707	3	44	use	use	NOUN
ihlr-21707	3	45	b.	b.	NOUN
ihlr-21707	3	46	delaying	delay	VERB
ihlr-21707	3	47	generic	generic	ADJ
ihlr-21707	3	48	entry	entry	NOUN
ihlr-21707	3	49	potential	potential	ADJ
ihlr-21707	3	50	abuses	abuse	NOUN
ihlr-21707	3	51	1	1	NUM
ihlr-21707	3	52	.	.	PUNCT
ihlr-21707	3	53	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	3	54	companies	company	NOUN
ihlr-21707	3	55	creating	create	VERB
ihlr-21707	3	56	their	their	PRON
ihlr-21707	3	57	own	own	ADJ
ihlr-21707	3	58	philanthropies	philanthropy	NOUN
ihlr-21707	3	59	then	then	ADV
ihlr-21707	3	60	funding	fund	VERB
ihlr-21707	3	61	the	the	DET
ihlr-21707	3	62	2	2	NUM
ihlr-21707	3	63	.	.	PUNCT
ihlr-21707	3	64	limiting	limit	VERB
ihlr-21707	3	65	the	the	DET
ihlr-21707	3	66	field	field	NOUN
ihlr-21707	3	67	of	of	ADP
ihlr-21707	3	68	ideas	idea	NOUN
ihlr-21707	3	69	to	to	ADP
ihlr-21707	3	70	the	the	DET
ihlr-21707	3	71	ideas	idea	NOUN
ihlr-21707	3	72	heavily	heavily	ADV
ihlr-21707	3	73	funded	fund	VERB
ihlr-21707	3	74	by	by	ADP
ihlr-21707	3	75	corporations	corporation	NOUN
ihlr-21707	3	76	http://doi.org/10.18060/3911.0033	http://doi.org/10.18060/3911.0033	ADJ
ihlr-21707	3	77	potential	potential	ADJ
ihlr-21707	3	78	benefits	benefit	NOUN
ihlr-21707	3	79	1	1	NUM
ihlr-21707	3	80	.	.	PUNCT
ihlr-21707	3	81	increase	increase	VERB
ihlr-21707	3	82	innovation	innovation	NOUN
ihlr-21707	3	83	through	through	ADP
ihlr-21707	3	84	nonprofit	nonprofit	ADJ
ihlr-21707	3	85	funding	funding	NOUN
ihlr-21707	3	86	of	of	ADP
ihlr-21707	3	87	research	research	NOUN
ihlr-21707	3	88	and	and	CCONJ
ihlr-21707	3	89	development	development	NOUN
ihlr-21707	3	90	2	2	NUM
ihlr-21707	3	91	.	.	PUNCT
ihlr-21707	3	92	economic	economic	ADJ
ihlr-21707	3	93	repurposing	repurposing	NOUN
ihlr-21707	3	94	of	of	ADP
ihlr-21707	3	95	drug	drug	NOUN
ihlr-21707	3	96	example	example	NOUN
ihlr-21707	3	97	:	:	PUNCT
ihlr-21707	3	98	cystic	cystic	ADJ
ihlr-21707	3	99	fibrosis	fibrosis	NOUN
ihlr-21707	3	100	foundation	foundation	NOUN
ihlr-21707	3	101	collaboration	collaboration	NOUN
ihlr-21707	3	102	with	with	ADP
ihlr-21707	3	103	vertex	vertex	NOUN
ihlr-21707	3	104	pharmaceuticals	pharmaceuticals	PROPN
ihlr-21707	3	105	a.	a.	PROPN
ihlr-21707	3	106	federal	federal	PROPN
ihlr-21707	3	107	tax	tax	PROPN
ihlr-21707	3	108	re	re	NOUN
ihlr-21707	3	109	-	-	NOUN
ihlr-21707	3	110	evaluation	evaluation	NOUN
ihlr-21707	3	111	for	for	ADP
ihlr-21707	3	112	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	3	113	representatives	representative	NOUN
ihlr-21707	3	114	b.	b.	PROPN
ihlr-21707	3	115	use	use	NOUN
ihlr-21707	3	116	of	of	ADP
ihlr-21707	3	117	modified	modify	VERB
ihlr-21707	3	118	venture	venture	NOUN
ihlr-21707	3	119	philanthropy	philanthropy	NOUN
ihlr-21707	3	120	1	1	NUM
ihlr-21707	3	121	.	.	PUNCT
ihlr-21707	3	122	utilizing	utilize	VERB
ihlr-21707	3	123	private	private	ADJ
ihlr-21707	3	124	nonprofit	nonprofit	ADJ
ihlr-21707	3	125	foundations	foundation	NOUN
ihlr-21707	3	126	with	with	ADP
ihlr-21707	3	127	“	"	PUNCT
ihlr-21707	3	128	program	program	NOUN
ihlr-21707	3	129	-	-	PUNCT
ihlr-21707	3	130	support	support	NOUN
ihlr-21707	3	131	”	"	PUNCT
ihlr-21707	3	132	grants	grant	NOUN
ihlr-21707	3	133	2	2	NUM
ihlr-21707	3	134	.	.	PUNCT
ihlr-21707	3	135	creating	create	VERB
ihlr-21707	3	136	own	own	ADJ
ihlr-21707	3	137	private	private	ADJ
ihlr-21707	3	138	,	,	PUNCT
ihlr-21707	3	139	operating	operating	NOUN
ihlr-21707	3	140	,	,	PUNCT
ihlr-21707	3	141	foundations	foundation	NOUN
ihlr-21707	3	142	a.	a.	NOUN
ihlr-21707	3	143	the	the	DET
ihlr-21707	3	144	issue	issue	NOUN
ihlr-21707	3	145	:	:	PUNCT
ihlr-21707	3	146	increasing	increase	VERB
ihlr-21707	3	147	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	3	148	prices	price	NOUN
ihlr-21707	3	149	here	here	ADV
ihlr-21707	3	150	’s	’	VERB
ihlr-21707	3	151	exactly	exactly	ADV
ihlr-21707	3	152	how	how	SCONJ
ihlr-21707	3	153	the	the	DET
ihlr-21707	3	154	united	united	PROPN
ihlr-21707	3	155	states	states	PROPN
ihlr-21707	3	156	spends	spend	VERB
ihlr-21707	3	157	$	$	SYM
ihlr-21707	3	158	2.9	2.9	NUM
ihlr-21707	3	159	trillion	trillion	NUM
ihlr-21707	3	160	on	on	ADP
ihlr-21707	3	161	health	health	NOUN
ihlr-21707	3	162	care	care	NOUN
ihlr-21707	3	163	i	i	PROPN
ihlr-21707	3	164	d.	d.	NOUN
ihlr-21707	3	165	prescription	prescription	NOUN
ihlr-21707	3	166	drugs	drug	NOUN
ihlr-21707	3	167	to	to	PART
ihlr-21707	3	168	lead	lead	VERB
ihlr-21707	3	169	trend	trend	NOUN
ihlr-21707	3	170	of	of	ADP
ihlr-21707	3	171	health	health	NOUN
ihlr-21707	3	172	care	care	NOUN
ihlr-21707	3	173	price	price	NOUN
ihlr-21707	3	174	increases	increase	NOUN
ihlr-21707	3	175	,	,	PUNCT
ihlr-21707	3	176	b.	b.	NOUN
ihlr-21707	3	177	why	why	SCONJ
ihlr-21707	3	178	prescription	prescription	NOUN
ihlr-21707	3	179	affordability	affordability	NOUN
ihlr-21707	3	180	is	be	AUX
ihlr-21707	3	181	important	important	ADJ
ihlr-21707	3	182	c.	c.	NOUN
ihlr-21707	3	183	“	"	PUNCT
ihlr-21707	3	184	phrma	phrma	PROPN
ihlr-21707	3	185	’s	’s	PART
ihlr-21707	3	186	”	"	PUNCT
ihlr-21707	3	187	contributions	contribution	NOUN
ihlr-21707	3	188	to	to	ADP
ihlr-21707	3	189	the	the	DET
ihlr-21707	3	190	pricing	pricing	NOUN
ihlr-21707	3	191	problem	problem	NOUN
ihlr-21707	3	192	d.	d.	PROPN
ihlr-21707	3	193	general	general	PROPN
ihlr-21707	3	194	outline	outline	PROPN
ihlr-21707	3	195	health	health	NOUN
ihlr-21707	3	196	premium	premium	NOUN
ihlr-21707	3	197	cost	cost	NOUN
ihlr-21707	3	198	trends	trend	NOUN
ihlr-21707	3	199	steady	steady	ADJ
ihlr-21707	3	200	for	for	ADP
ihlr-21707	3	201	2015	2015	NUM
ihlr-21707	3	202	,	,	PUNCT
ihlr-21707	3	203	but	but	CCONJ
ihlr-21707	3	204	drug	drug	NOUN
ihlr-21707	3	205	costs	cost	NOUN
ihlr-21707	3	206	expected	expect	VERB
ihlr-21707	3	207	to	to	PART
ihlr-21707	3	208	rise	rise	VERB
ihlr-21707	3	209	see	see	VERB
ihlr-21707	3	210	generally	generally	ADV
ihlr-21707	3	211	study	study	NOUN
ihlr-21707	3	212	shows	show	VERB
ihlr-21707	3	213	about	about	ADV
ihlr-21707	3	214	48	48	NUM
ihlr-21707	3	215	%	%	NOUN
ihlr-21707	3	216	of	of	ADP
ihlr-21707	3	217	americans	americans	PROPN
ihlr-21707	3	218	take	take	VERB
ihlr-21707	3	219	at	at	ADV
ihlr-21707	3	220	least	least	ADV
ihlr-21707	3	221	one	one	NUM
ihlr-21707	3	222	prescription	prescription	NOUN
ihlr-21707	3	223	drug	drug	NOUN
ihlr-21707	3	224	see	see	VERB
ihlr-21707	3	225	generally	generally	ADV
ihlr-21707	3	226	baby	baby	NOUN
ihlr-21707	3	227	boomers	boomer	NOUN
ihlr-21707	3	228	just	just	ADV
ihlr-21707	3	229	how	how	SCONJ
ihlr-21707	3	230	many	many	ADJ
ihlr-21707	3	231	baby	baby	NOUN
ihlr-21707	3	232	boomers	boomer	NOUN
ihlr-21707	3	233	are	be	AUX
ihlr-21707	3	234	there	there	ADV
ihlr-21707	3	235	?	?	PUNCT
ihlr-21707	4	1	nearly	nearly	ADV
ihlr-21707	4	2	7	7	NUM
ihlr-21707	4	3	in	in	ADP
ihlr-21707	4	4	10	10	NUM
ihlr-21707	4	5	americans	americans	PROPN
ihlr-21707	4	6	take	take	VERB
ihlr-21707	4	7	prescription	prescription	NOUN
ihlr-21707	4	8	drugs	drug	NOUN
ihlr-21707	4	9	,	,	PUNCT
ihlr-21707	4	10	mayo	mayo	NOUN
ihlr-21707	4	11	clinic	clinic	PROPN
ihlr-21707	4	12	,	,	PUNCT
ihlr-21707	4	13	olmsted	olmsted	PROPN
ihlr-21707	4	14	medical	medical	ADJ
ihlr-21707	4	15	center	center	NOUN
ihlr-21707	4	16	find	find	VERB
ihlr-21707	4	17	the	the	DET
ihlr-21707	4	18	good	good	PROPN
ihlr-21707	4	19	news	news	PROPN
ihlr-21707	4	20	on	on	ADP
ihlr-21707	4	21	fda	fda	PROPN
ihlr-21707	4	22	and	and	CCONJ
ihlr-21707	4	23	andas	anda	NOUN
ihlr-21707	4	24	,	,	PUNCT
ihlr-21707	4	25	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	4	26	spending	spending	NOUN
ihlr-21707	4	27	available	available	ADJ
ihlr-21707	4	28	at	at	ADP
ihlr-21707	4	29	a.	a.	NOUN
ihlr-21707	4	30	the	the	DET
ihlr-21707	4	31	legislation	legislation	NOUN
ihlr-21707	4	32	1	1	NUM
ihlr-21707	4	33	.	.	PUNCT
ihlr-21707	5	1	hatch	hatch	NOUN
ihlr-21707	5	2	-	-	PUNCT
ihlr-21707	5	3	waxman	waxman	PROPN
ihlr-21707	5	4	act	act	VERB
ihlr-21707	5	5	the	the	DET
ihlr-21707	5	6	hatch	hatch	NOUN
ihlr-21707	5	7	-	-	PUNCT
ihlr-21707	5	8	waxman	waxman	NOUN
ihlr-21707	5	9	act--25	act--25	PROPN
ihlr-21707	5	10	years	year	NOUN
ihlr-21707	5	11	later	later	ADV
ihlr-21707	5	12	:	:	PUNCT
ihlr-21707	5	13	keeping	keep	VERB
ihlr-21707	5	14	the	the	DET
ihlr-21707	5	15	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	5	16	scales	scale	NOUN
ihlr-21707	5	17	balanced	balance	VERB
ihlr-21707	6	1	i	i	PRON
ihlr-21707	6	2	d	d	PROPN
ihlr-21707	7	1	i	i	PROPN
ihlr-21707	7	2	d	d	PROPN
ihlr-21707	7	3	i	i	PROPN
ihlr-21707	7	4	d	d	PROPN
ihlr-21707	7	5	2	2	X
ihlr-21707	7	6	.	.	PUNCT
ihlr-21707	7	7	patient	patient	ADJ
ihlr-21707	7	8	protection	protection	NOUN
ihlr-21707	7	9	and	and	CCONJ
ihlr-21707	7	10	affordable	affordable	ADJ
ihlr-21707	7	11	care	care	NOUN
ihlr-21707	7	12	act	act	NOUN
ihlr-21707	7	13	(	(	PUNCT
ihlr-21707	7	14	“	"	PUNCT
ihlr-21707	7	15	aca”)(“obamacare	aca”)(“obamacare	PROPN
ihlr-21707	7	16	”	"	PUNCT
ihlr-21707	7	17	)	)	PUNCT
ihlr-21707	7	18	a.	a.	NOUN
ihlr-21707	8	1	the	the	DET
ihlr-21707	8	2	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	8	3	tax	tax	NOUN
ihlr-21707	8	4	all	all	DET
ihlr-21707	8	5	new	new	ADJ
ihlr-21707	8	6	taxes	taxis	NOUN
ihlr-21707	8	7	for	for	ADP
ihlr-21707	8	8	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	8	9	and	and	CCONJ
ihlr-21707	8	10	device	device	NOUN
ihlr-21707	8	11	manufacturers	manufacturer	NOUN
ihlr-21707	8	12	/	/	SYM
ihlr-21707	8	13	importers	importer	NOUN
ihlr-21707	8	14	/	/	SYM
ihlr-21707	8	15	distributors	distributor	NOUN
ihlr-21707	9	1	i	i	NOUN
ihlr-21707	9	2	d	d	PROPN
ihlr-21707	9	3	i	i	PROPN
ihlr-21707	9	4	d	d	PROPN
ihlr-21707	9	5	supra	supra	PROPN
ihlr-21707	9	6	see	see	VERB
ihlr-21707	9	7	also	also	ADV
ihlr-21707	9	8	annual	annual	ADJ
ihlr-21707	9	9	fee	fee	NOUN
ihlr-21707	9	10	imposed	impose	VERB
ihlr-21707	9	11	on	on	ADP
ihlr-21707	9	12	prescription	prescription	NOUN
ihlr-21707	9	13	drug	drug	NOUN
ihlr-21707	9	14	manufacturers	manufacturer	NOUN
ihlr-21707	9	15	and	and	CCONJ
ihlr-21707	9	16	importers	importer	NOUN
ihlr-21707	9	17	annual	annual	ADJ
ihlr-21707	9	18	fee	fee	NOUN
ihlr-21707	9	19	see	see	VERB
ihlr-21707	9	20	generally	generally	ADV
ihlr-21707	9	21	new	new	ADJ
ihlr-21707	9	22	taxes	taxis	NOUN
ihlr-21707	9	23	for	for	ADP
ihlr-21707	9	24	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	9	25	and	and	CCONJ
ihlr-21707	9	26	device	device	NOUN
ihlr-21707	9	27	manufacturers	manufacturer	NOUN
ihlr-21707	9	28	/	/	SYM
ihlr-21707	9	29	importers	importer	NOUN
ihlr-21707	9	30	/	/	SYM
ihlr-21707	9	31	distributors	distributor	NOUN
ihlr-21707	10	1	i	i	PRON
ihlr-21707	10	2	d.	d.	VERB
ihlr-21707	10	3	i	i	PRON
ihlr-21707	10	4	d.	d.	PROPN
ihlr-21707	10	5	i	i	PROPN
ihlr-21707	10	6	d.	d.	PROPN
ihlr-21707	10	7	b.	b.	PROPN
ihlr-21707	10	8	national	national	PROPN
ihlr-21707	10	9	physician	physician	PROPN
ihlr-21707	10	10	payment	payment	NOUN
ihlr-21707	10	11	transparency	transparency	NOUN
ihlr-21707	10	12	program	program	NOUN
ihlr-21707	10	13	(	(	PUNCT
ihlr-21707	10	14	“	"	PUNCT
ihlr-21707	10	15	open	open	ADJ
ihlr-21707	10	16	payments	payment	NOUN
ihlr-21707	10	17	”	"	PUNCT
ihlr-21707	10	18	)	)	PUNCT
ihlr-21707	10	19	c.	c.	PROPN
ihlr-21707	10	20	congressional	congressional	ADJ
ihlr-21707	10	21	funding	funding	NOUN
ihlr-21707	10	22	of	of	ADP
ihlr-21707	10	23	research	research	PROPN
ihlr-21707	10	24	&	&	CCONJ
ihlr-21707	10	25	development	development	PROPN
ihlr-21707	11	1	i	i	PROPN
ihlr-21707	11	2	d.	d.	PROPN
ihlr-21707	11	3	see	see	VERB
ihlr-21707	11	4	also	also	ADV
ihlr-21707	11	5	annual	annual	ADJ
ihlr-21707	11	6	fee	fee	NOUN
ihlr-21707	11	7	imposed	impose	VERB
ihlr-21707	11	8	on	on	ADP
ihlr-21707	11	9	prescription	prescription	NOUN
ihlr-21707	11	10	drug	drug	NOUN
ihlr-21707	11	11	manufacturers	manufacturer	NOUN
ihlr-21707	11	12	and	and	CCONJ
ihlr-21707	11	13	importers	importer	NOUN
ihlr-21707	11	14	supra	supra	PROPN
ihlr-21707	11	15	see	see	VERB
ihlr-21707	11	16	i	i	PROPN
ihlr-21707	11	17	d.	d.	PROPN
ihlr-21707	11	18	marketing	marketing	PROPN
ihlr-21707	11	19	and	and	CCONJ
ihlr-21707	11	20	direct	direct	ADJ
ihlr-21707	11	21	-	-	PUNCT
ihlr-21707	11	22	to	to	ADP
ihlr-21707	11	23	-	-	PUNCT
ihlr-21707	11	24	consumer	consumer	NOUN
ihlr-21707	11	25	advertising	advertising	NOUN
ihlr-21707	11	26	(	(	PUNCT
ihlr-21707	11	27	“	"	PUNCT
ihlr-21707	11	28	dtca	dtca	ADJ
ihlr-21707	11	29	”	"	PUNCT
ihlr-21707	11	30	)	)	PUNCT
ihlr-21707	11	31	of	of	ADP
ihlr-21707	11	32	pharmaceuticals	pharmaceutical	NOUN
ihlr-21707	11	33	,	,	PUNCT
ihlr-21707	11	34	see	see	VERB
ihlr-21707	11	35	generally	generally	ADV
ihlr-21707	11	36	open	open	ADJ
ihlr-21707	11	37	payments	payment	NOUN
ihlr-21707	11	38	,	,	PUNCT
ihlr-21707	11	39	i	i	PRON
ihlr-21707	11	40	d.	d.	PROPN
ihlr-21707	11	41	i	i	PRON
ihlr-21707	11	42	d.	d.	PROPN
ihlr-21707	11	43	see	see	VERB
ihlr-21707	11	44	generally	generally	ADV
ihlr-21707	11	45	.	.	PUNCT
ihlr-21707	12	1	i	i	PRON
ihlr-21707	12	2	d	d	PROPN
ihlr-21707	12	3	i	i	PRON
ihlr-21707	12	4	d	d	NOUN
ihlr-21707	12	5	see	see	VERB
ihlr-21707	12	6	generally	generally	ADV
ihlr-21707	12	7	i	i	PROPN
ihlr-21707	12	8	d	d	PROPN
ihlr-21707	12	9	.	.	PUNCT
ihlr-21707	13	1	b.	b.	PROPN
ihlr-21707	14	1	the	the	DET
ihlr-21707	14	2	judiciary	judiciary	NOUN
ihlr-21707	14	3	(	(	PUNCT
ihlr-21707	14	4	ftc	ftc	PROPN
ihlr-21707	14	5	v.	v.	ADP
ihlr-21707	14	6	actavis	actavis	PROPN
ihlr-21707	14	7	)	)	PUNCT
ihlr-21707	14	8	ftc	ftc	PROPN
ihlr-21707	14	9	v.	v.	ADP
ihlr-21707	14	10	actavis	actavis	PROPN
ihlr-21707	14	11	actavis	actavis	PROPN
ihlr-21707	14	12	ftc	ftc	PROPN
ihlr-21707	14	13	v.	v.	ADP
ihlr-21707	14	14	actavis	actavis	PROPN
ihlr-21707	14	15	a.	a.	NOUN
ihlr-21707	14	16	introduction	introduction	NOUN
ihlr-21707	14	17	big	big	PROPN
ihlr-21707	14	18	pharma	pharma	PROPN
ihlr-21707	14	19	’s	’s	PART
ihlr-21707	14	20	favorite	favorite	ADJ
ihlr-21707	14	21	prescription	prescription	NOUN
ihlr-21707	14	22	:	:	PUNCT
ihlr-21707	14	23	higher	high	ADJ
ihlr-21707	14	24	prices	price	NOUN
ihlr-21707	14	25	,	,	PUNCT
ihlr-21707	14	26	see	see	VERB
ihlr-21707	14	27	also	also	ADV
ihlr-21707	14	28	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	14	29	industry	industry	NOUN
ihlr-21707	14	30	gets	get	VERB
ihlr-21707	14	31	high	high	ADJ
ihlr-21707	14	32	off	off	ADP
ihlr-21707	14	33	of	of	ADP
ihlr-21707	14	34	fat	fat	ADJ
ihlr-21707	14	35	profits	profit	NOUN
ihlr-21707	14	36	,	,	PUNCT
ihlr-21707	14	37	i	i	PRON
ihlr-21707	14	38	d.	d.	PROPN
ihlr-21707	14	39	competition	competition	NOUN
ihlr-21707	14	40	ahead	ahead	ADV
ihlr-21707	14	41	?	?	PUNCT
ihlr-21707	15	1	the	the	DET
ihlr-21707	15	2	legal	legal	ADJ
ihlr-21707	15	3	landscape	landscape	NOUN
ihlr-21707	15	4	for	for	ADP
ihlr-21707	15	5	reverse	reverse	ADJ
ihlr-21707	15	6	payment	payment	NOUN
ihlr-21707	15	7	settlements	settlement	NOUN
ihlr-21707	15	8	after	after	ADP
ihlr-21707	15	9	federal	federal	ADJ
ihlr-21707	15	10	trade	trade	PROPN
ihlr-21707	15	11	commission	commission	PROPN
ihlr-21707	15	12	v.	v.	ADP
ihlr-21707	15	13	actavis	actavis	PROPN
ihlr-21707	15	14	,	,	PUNCT
ihlr-21707	15	15	inc	inc	PROPN
ihlr-21707	15	16	.	.	PUNCT
ihlr-21707	16	1	i	i	PRON
ihlr-21707	16	2	d.	d.	PROPN
ihlr-21707	17	1	i	i	PRON
ihlr-21707	17	2	d.	d.	PROPN
ihlr-21707	17	3	see	see	VERB
ihlr-21707	17	4	supra	supra	PROPN
ihlr-21707	17	5	b.	b.	PROPN
ihlr-21707	17	6	patent	patent	NOUN
ihlr-21707	17	7	and	and	CCONJ
ihlr-21707	17	8	antitrust	antitrust	ADJ
ihlr-21707	17	9	laws	law	NOUN
ihlr-21707	17	10	see	see	VERB
ihlr-21707	17	11	generally	generally	ADV
ihlr-21707	17	12	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	17	13	industry	industry	NOUN
ihlr-21707	17	14	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	17	15	industry	industry	NOUN
ihlr-21707	17	16	supra	supra	PROPN
ihlr-21707	17	17	pharmaceutical	pharmaceutical	PROPN
ihlr-21707	17	18	industry	industry	NOUN
ihlr-21707	17	19	supra	supra	PROPN
ihlr-21707	17	20	pharmaceutical	pharmaceutical	PROPN
ihlr-21707	17	21	antitrust	antitrust	NOUN
ihlr-21707	17	22	:	:	PUNCT
ihlr-21707	17	23	delayed	delay	VERB
ihlr-21707	17	24	generic	generic	ADJ
ihlr-21707	17	25	entry	entry	NOUN
ihlr-21707	17	26	cases	case	NOUN
ihlr-21707	17	27	frequently	frequently	ADV
ihlr-21707	17	28	asked	ask	VERB
ihlr-21707	17	29	questions	question	NOUN
ihlr-21707	17	30	on	on	ADP
ihlr-21707	17	31	patents	patent	NOUN
ihlr-21707	17	32	and	and	CCONJ
ihlr-21707	17	33	exclusivity	exclusivity	NOUN
ihlr-21707	17	34	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	17	35	corporations	corporation	NOUN
ihlr-21707	17	36	and	and	CCONJ
ihlr-21707	17	37	medical	medical	ADJ
ihlr-21707	17	38	research	research	NOUN
ihlr-21707	17	39	drug	drug	NOUN
ihlr-21707	17	40	patent	patent	NOUN
ihlr-21707	17	41	expirations	expiration	NOUN
ihlr-21707	17	42	and	and	CCONJ
ihlr-21707	17	43	the	the	DET
ihlr-21707	17	44	“	"	PUNCT
ihlr-21707	17	45	patent	patent	NOUN
ihlr-21707	17	46	cliff	cliff	NOUN
ihlr-21707	17	47	”	"	PUNCT
ihlr-21707	17	48	supra	supra	PROPN
ihlr-21707	18	1	i	i	PROPN
ihlr-21707	18	2	d.	d.	PROPN
ihlr-21707	18	3	c.	c.	PROPN
ihlr-21707	18	4	generic	generic	PROPN
ihlr-21707	18	5	pharmaceutical	pharmaceutical	PROPN
ihlr-21707	18	6	company	company	NOUN
ihlr-21707	18	7	issues	issue	VERB
ihlr-21707	18	8	prescriptions	prescription	NOUN
ihlr-21707	18	9	for	for	ADP
ihlr-21707	18	10	change	change	NOUN
ihlr-21707	18	11	:	:	PUNCT
ihlr-21707	18	12	the	the	DET
ihlr-21707	18	13	hatch	hatch	NOUN
ihlr-21707	18	14	-	-	PUNCT
ihlr-21707	18	15	waxman	waxman	PROPN
ihlr-21707	18	16	act	act	NOUN
ihlr-21707	18	17	and	and	CCONJ
ihlr-21707	18	18	new	new	ADJ
ihlr-21707	18	19	legislation	legislation	NOUN
ihlr-21707	18	20	to	to	PART
ihlr-21707	18	21	increase	increase	VERB
ihlr-21707	18	22	the	the	DET
ihlr-21707	18	23	availability	availability	NOUN
ihlr-21707	18	24	of	of	ADP
ihlr-21707	18	25	generic	generic	ADJ
ihlr-21707	18	26	drugs	drug	NOUN
ihlr-21707	18	27	to	to	ADP
ihlr-21707	18	28	consumers	consumer	NOUN
ihlr-21707	18	29	supra	supra	PROPN
ihlr-21707	18	30	drug	drug	NOUN
ihlr-21707	18	31	prices	price	NOUN
ihlr-21707	18	32	defy	defy	VERB
ihlr-21707	18	33	gravity	gravity	NOUN
ihlr-21707	18	34	,	,	PUNCT
ihlr-21707	18	35	doubling	doubling	NOUN
ihlr-21707	18	36	or	or	CCONJ
ihlr-21707	18	37	dozens	dozen	NOUN
ihlr-21707	18	38	of	of	ADP
ihlr-21707	18	39	products	product	NOUN
ihlr-21707	18	40	,	,	PUNCT
ihlr-21707	18	41	the	the	DET
ihlr-21707	18	42	industry	industry	NOUN
ihlr-21707	18	43	i	i	PROPN
ihlr-21707	18	44	d.	d.	PROPN
ihlr-21707	18	45	be	be	AUX
ihlr-21707	18	46	wary	wary	ADJ
ihlr-21707	18	47	of	of	ADP
ihlr-21707	18	48	stratospheric	stratospheric	ADJ
ihlr-21707	18	49	increases	increase	NOUN
ihlr-21707	18	50	in	in	ADP
ihlr-21707	18	51	generic	generic	ADJ
ihlr-21707	18	52	drug	drug	NOUN
ihlr-21707	18	53	prices	price	NOUN
ihlr-21707	18	54	,	,	PUNCT
ihlr-21707	18	55	i	i	PRON
ihlr-21707	18	56	d.	d.	PROPN
ihlr-21707	18	57	i	i	PRON
ihlr-21707	18	58	d.	d.	PROPN
ihlr-21707	18	59	expose	expose	VERB
ihlr-21707	18	60	reveals	reveal	VERB
ihlr-21707	18	61	why	why	SCONJ
ihlr-21707	18	62	we	we	PRON
ihlr-21707	18	63	no	no	ADV
ihlr-21707	18	64	longer	long	ADV
ihlr-21707	18	65	trust	trust	VERB
ihlr-21707	18	66	all	all	DET
ihlr-21707	18	67	generic	generic	ADJ
ihlr-21707	18	68	drugs	drug	NOUN
ihlr-21707	18	69	d.	d.	PROPN
ihlr-21707	18	70	increased	increase	VERB
ihlr-21707	18	71	marketing	marketing	NOUN
ihlr-21707	18	72	expenditures	expenditure	NOUN
ihlr-21707	18	73	detailing	detail	VERB
ihlr-21707	18	74	how	how	SCONJ
ihlr-21707	18	75	a	a	DET
ihlr-21707	18	76	cabal	cabal	NOUN
ihlr-21707	18	77	keeps	keep	VERB
ihlr-21707	18	78	generics	generics	PROPN
ihlr-21707	18	79	scarce	scarce	ADJ
ihlr-21707	18	80	supra	supra	PROPN
ihlr-21707	18	81	see	see	VERB
ihlr-21707	18	82	also	also	ADV
ihlr-21707	18	83	,	,	PUNCT
ihlr-21707	18	84	,	,	PUNCT
ihlr-21707	18	85	supra	supra	PROPN
ihlr-21707	18	86	there	there	PRON
ihlr-21707	18	87	ai	ai	VERB
ihlr-21707	18	88	n’t	not	PART
ihlr-21707	18	89	no	no	DET
ihlr-21707	18	90	such	such	ADJ
ihlr-21707	18	91	thing	thing	NOUN
ihlr-21707	18	92	as	as	ADP
ihlr-21707	18	93	a	a	DET
ihlr-21707	18	94	free	free	ADJ
ihlr-21707	18	95	lunch	lunch	NOUN
ihlr-21707	18	96	:	:	PUNCT
ihlr-21707	18	97	a	a	DET
ihlr-21707	18	98	look	look	NOUN
ihlr-21707	18	99	at	at	ADP
ihlr-21707	18	100	state	state	NOUN
ihlr-21707	18	101	disclosure	disclosure	NOUN
ihlr-21707	18	102	laws	law	NOUN
ihlr-21707	18	103	and	and	CCONJ
ihlr-21707	18	104	the	the	DET
ihlr-21707	18	105	effect	effect	NOUN
ihlr-21707	18	106	on	on	ADP
ihlr-21707	18	107	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	18	108	company	company	NOUN
ihlr-21707	18	109	marketing	marketing	NOUN
ihlr-21707	18	110	see	see	VERB
ihlr-21707	18	111	also	also	ADV
ihlr-21707	18	112	big	big	ADJ
ihlr-21707	18	113	bad	bad	ADJ
ihlr-21707	18	114	pharma	pharma	NOUN
ihlr-21707	18	115	:	:	PUNCT
ihlr-21707	18	116	an	an	DET
ihlr-21707	18	117	ethical	ethical	ADJ
ihlr-21707	18	118	analysis	analysis	NOUN
ihlr-21707	18	119	of	of	ADP
ihlr-21707	18	120	physician	physician	NOUN
ihlr-21707	18	121	-	-	PUNCT
ihlr-21707	18	122	directed	direct	VERB
ihlr-21707	18	123	and	and	CCONJ
ihlr-21707	18	124	consumer	consumer	NOUN
ihlr-21707	18	125	-	-	PUNCT
ihlr-21707	18	126	directed	direct	VERB
ihlr-21707	18	127	marketing	marketing	NOUN
ihlr-21707	18	128	tactics	tactic	NOUN
ihlr-21707	18	129	the	the	DET
ihlr-21707	18	130	impact	impact	NOUN
ihlr-21707	18	131	of	of	ADP
ihlr-21707	18	132	direct	direct	ADJ
ihlr-21707	18	133	-	-	PUNCT
ihlr-21707	18	134	to	to	ADP
ihlr-21707	18	135	-	-	PUNCT
ihlr-21707	18	136	consumer	consumer	NOUN
ihlr-21707	18	137	advertising	advertising	NOUN
ihlr-21707	18	138	big	big	ADJ
ihlr-21707	18	139	bad	bad	ADJ
ihlr-21707	18	140	pharma	pharma	NOUN
ihlr-21707	18	141	:	:	PUNCT
ihlr-21707	18	142	an	an	DET
ihlr-21707	18	143	ethical	ethical	ADJ
ihlr-21707	18	144	analysis	analysis	NOUN
ihlr-21707	18	145	of	of	ADP
ihlr-21707	18	146	physician	physician	NOUN
ihlr-21707	18	147	-	-	PUNCT
ihlr-21707	18	148	directed	direct	VERB
ihlr-21707	18	149	and	and	CCONJ
ihlr-21707	18	150	consumer	consumer	NOUN
ihlr-21707	18	151	-	-	PUNCT
ihlr-21707	18	152	directed	direct	VERB
ihlr-21707	18	153	marketing	marketing	NOUN
ihlr-21707	18	154	tactics	tactic	NOUN
ihlr-21707	18	155	i	i	PROPN
ihlr-21707	18	156	d.	d.	PROPN
ihlr-21707	18	157	sorrell	sorrell	PROPN
ihlr-21707	18	158	v.	v.	PROPN
ihlr-21707	18	159	ims	ims	PROPN
ihlr-21707	18	160	health	health	PROPN
ihlr-21707	18	161	see	see	VERB
ihlr-21707	18	162	generally	generally	ADV
ihlr-21707	18	163	health	health	NOUN
ihlr-21707	18	164	care	care	NOUN
ihlr-21707	18	165	costs	cost	NOUN
ihlr-21707	18	166	:	:	PUNCT
ihlr-21707	18	167	a	a	DET
ihlr-21707	18	168	primer	primer	NOUN
ihlr-21707	18	169	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	18	170	detailing	detail	VERB
ihlr-21707	18	171	definition	definition	NOUN
ihlr-21707	18	172	supra	supra	PROPN
ihlr-21707	18	173	the	the	DET
ihlr-21707	18	174	pharma	pharma	PROPN
ihlr-21707	18	175	marketing	marketing	NOUN
ihlr-21707	18	176	glossary	glossary	NOUN
ihlr-21707	18	177	persuading	persuade	VERB
ihlr-21707	18	178	the	the	DET
ihlr-21707	18	179	prescribers	prescriber	NOUN
ihlr-21707	18	180	:	:	PUNCT
ihlr-21707	18	181	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	18	182	industry	industry	NOUN
ihlr-21707	18	183	marketing	marketing	NOUN
ihlr-21707	18	184	and	and	CCONJ
ihlr-21707	18	185	its	its	PRON
ihlr-21707	18	186	influence	influence	NOUN
ihlr-21707	18	187	on	on	ADP
ihlr-21707	18	188	physicians	physician	NOUN
ihlr-21707	18	189	and	and	CCONJ
ihlr-21707	18	190	patients	patient	NOUN
ihlr-21707	18	191	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	18	192	detailing	detailing	NOUN
ihlr-21707	18	193	is	be	AUX
ihlr-21707	18	194	not	not	PART
ihlr-21707	18	195	for	for	ADP
ihlr-21707	18	196	everyone	everyone	PRON
ihlr-21707	18	197	:	:	PUNCT
ihlr-21707	18	198	side	side	ADJ
ihlr-21707	18	199	effects	effect	NOUN
ihlr-21707	18	200	may	may	AUX
ihlr-21707	18	201	include	include	VERB
ihlr-21707	18	202	sub	sub	ADJ
ihlr-21707	18	203	-	-	ADJ
ihlr-21707	18	204	optimal	optimal	ADJ
ihlr-21707	18	205	prescribing	prescribing	NOUN
ihlr-21707	18	206	decisions	decision	NOUN
ihlr-21707	18	207	,	,	PUNCT
ihlr-21707	18	208	compromised	compromise	VERB
ihlr-21707	18	209	patient	patient	ADJ
ihlr-21707	18	210	health	health	NOUN
ihlr-21707	18	211	,	,	PUNCT
ihlr-21707	18	212	and	and	CCONJ
ihlr-21707	18	213	increased	increase	VERB
ihlr-21707	18	214	prescription	prescription	NOUN
ihlr-21707	18	215	drug	drug	NOUN
ihlr-21707	18	216	spending	spending	NOUN
ihlr-21707	18	217	supra	supra	NOUN
ihlr-21707	18	218	regulating	regulate	VERB
ihlr-21707	18	219	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	18	220	marketing	marketing	NOUN
ihlr-21707	18	221	after	after	ADP
ihlr-21707	18	222	sorrell	sorrell	PROPN
ihlr-21707	18	223	v.	v.	PROPN
ihlr-21707	18	224	ims	ims	PROPN
ihlr-21707	18	225	health	health	PROPN
ihlr-21707	18	226	inc	inc	PROPN
ihlr-21707	18	227	.	.	PUNCT
ihlr-21707	19	1	https://doi.org/10.1080/01947648.2012.714328	https://doi.org/10.1080/01947648.2012.714328	PROPN
ihlr-21707	20	1	sorrell	sorrell	PROPN
ihlr-21707	20	2	v.	v.	CCONJ
ihlr-21707	20	3	ims	ims	PROPN
ihlr-21707	20	4	health	health	PROPN
ihlr-21707	20	5	,	,	PUNCT
ihlr-21707	20	6	i	i	PROPN
ihlr-21707	20	7	d.	d.	PROPN
ihlr-21707	21	1	i	i	PROPN
ihlr-21707	21	2	d.	d.	PROPN
ihlr-21707	21	3	new	new	PROPN
ihlr-21707	21	4	reps	rep	NOUN
ihlr-21707	21	5	,	,	PUNCT
ihlr-21707	21	6	new	new	ADJ
ihlr-21707	21	7	rap	rap	NOUN
ihlr-21707	21	8	:	:	PUNCT
ihlr-21707	21	9	the	the	DET
ihlr-21707	21	10	counter	counter	NOUN
ihlr-21707	21	11	-	-	PROPN
ihlr-21707	21	12	detailers	detailer	NOUN
ihlr-21707	21	13	supra	supra	PROPN
ihlr-21707	21	14	i	i	PRON
ihlr-21707	21	15	d.	d.	NOUN
ihlr-21707	21	16	prescription	prescription	NOUN
ihlr-21707	21	17	drugs	drug	NOUN
ihlr-21707	21	18	:	:	PUNCT
ihlr-21707	21	19	academic	academic	ADJ
ihlr-21707	21	20	detailing	detailing	NOUN
ihlr-21707	21	21	see	see	VERB
ihlr-21707	21	22	i	i	PROPN
ihlr-21707	21	23	d.	d.	PROPN
ihlr-21707	21	24	supra	supra	PROPN
ihlr-21707	22	1	i	i	PRON
ihlr-21707	22	2	d.	d.	PROPN
ihlr-21707	22	3	see	see	VERB
ihlr-21707	22	4	generally	generally	ADV
ihlr-21707	22	5	resistance	resistance	NOUN
ihlr-21707	22	6	to	to	ADP
ihlr-21707	22	7	affordable	affordable	ADJ
ihlr-21707	22	8	care	care	NOUN
ihlr-21707	22	9	act	act	PROPN
ihlr-21707	22	10	continues	continue	VERB
ihlr-21707	22	11	nationwide	nationwide	ADJ
ihlr-21707	22	12	supra	supra	PROPN
ihlr-21707	22	13	sales	sale	NOUN
ihlr-21707	22	14	innovation	innovation	NOUN
ihlr-21707	22	15	and	and	CCONJ
ihlr-21707	22	16	metric	metric	ADJ
ihlr-21707	22	17	report	report	NOUN
ihlr-21707	22	18	,	,	PUNCT
ihlr-21707	22	19	2014	2014	NUM
ihlr-21707	22	20	,	,	PUNCT
ihlr-21707	22	21	e.	e.	PROPN
ihlr-21707	22	22	increasing	increase	VERB
ihlr-21707	22	23	costs	cost	NOUN
ihlr-21707	22	24	of	of	ADP
ihlr-21707	22	25	research	research	NOUN
ihlr-21707	22	26	&	&	CCONJ
ihlr-21707	22	27	development	development	PROPN
ihlr-21707	22	28	i	i	PROPN
ihlr-21707	22	29	d.	d.	PROPN
ihlr-21707	22	30	supra	supra	PROPN
ihlr-21707	22	31	drug	drug	PROPN
ihlr-21707	22	32	development	development	PROPN
ihlr-21707	22	33	r&d	r&d	PROPN
ihlr-21707	22	34	:	:	PUNCT
ihlr-21707	22	35	new	new	ADJ
ihlr-21707	22	36	transaction	transaction	NOUN
ihlr-21707	22	37	structures	structure	NOUN
ihlr-21707	22	38	i	i	PRON
ihlr-21707	22	39	d.	d.	PROPN
ihlr-21707	22	40	supra	supra	PROPN
ihlr-21707	22	41	supra	supra	PROPN
ihlr-21707	22	42	supra	supra	PROPN
ihlr-21707	22	43	supra	supra	PROPN
ihlr-21707	22	44	medicines	medicine	NOUN
ihlr-21707	22	45	:	:	PUNCT
ihlr-21707	22	46	costs	cost	NOUN
ihlr-21707	22	47	in	in	ADP
ihlr-21707	22	48	context	context	PROPN
ihlr-21707	22	49	supra	supra	PROPN
ihlr-21707	22	50	f.	f.	PROPN
ihlr-21707	22	51	increased	increase	VERB
ihlr-21707	22	52	medicare	medicare	PROPN
ihlr-21707	22	53	coverage	coverage	NOUN
ihlr-21707	23	1	i	i	PROPN
ihlr-21707	23	2	d.	d.	PROPN
ihlr-21707	23	3	more	more	ADJ
ihlr-21707	23	4	than	than	ADP
ihlr-21707	23	5	430	430	NUM
ihlr-21707	23	6	new	new	ADJ
ihlr-21707	23	7	medicines	medicine	NOUN
ihlr-21707	23	8	in	in	ADP
ihlr-21707	23	9	development	development	NOUN
ihlr-21707	23	10	for	for	ADP
ihlr-21707	23	11	top	top	ADJ
ihlr-21707	23	12	chronic	chronic	ADJ
ihlr-21707	23	13	diseases	disease	NOUN
ihlr-21707	23	14	affecting	affect	VERB
ihlr-21707	23	15	older	old	ADJ
ihlr-21707	23	16	americans	americans	PROPN
ihlr-21707	23	17	2015	2015	NUM
ihlr-21707	23	18	profile	profile	NOUN
ihlr-21707	23	19	:	:	PUNCT
ihlr-21707	23	20	biopharmaceutical	biopharmaceutical	ADJ
ihlr-21707	23	21	research	research	NOUN
ihlr-21707	23	22	industry	industry	NOUN
ihlr-21707	23	23	who	who	PRON
ihlr-21707	23	24	funds	fund	VERB
ihlr-21707	23	25	biomedical	biomedical	ADJ
ihlr-21707	23	26	research	research	NOUN
ihlr-21707	23	27	?	?	PUNCT
ihlr-21707	24	1	phrma	phrma	PROPN
ihlr-21707	24	2	member	member	NOUN
ihlr-21707	24	3	companies	company	NOUN
ihlr-21707	24	4	invested	invest	VERB
ihlr-21707	24	5	$	$	SYM
ihlr-21707	24	6	51.2	51.2	NUM
ihlr-21707	24	7	billion	billion	NUM
ihlr-21707	24	8	in	in	ADP
ihlr-21707	24	9	r&d	r&d	NOUN
ihlr-21707	24	10	in	in	ADP
ihlr-21707	24	11	2014	2014	NUM
ihlr-21707	24	12	i	i	PROPN
ihlr-21707	24	13	d.	d.	PROPN
ihlr-21707	24	14	pharmaceutical	pharmaceutical	PROPN
ihlr-21707	24	15	industry	industry	PROPN
ihlr-21707	24	16	supra	supra	PROPN
ihlr-21707	24	17	supra	supra	PROPN
ihlr-21707	24	18	supra	supra	PROPN
ihlr-21707	25	1	i	i	PRON
ihlr-21707	25	2	d.	d.	PROPN
ihlr-21707	26	1	i	i	PROPN
ihlr-21707	26	2	d.	d.	PROPN
ihlr-21707	26	3	medicare	medicare	PROPN
ihlr-21707	26	4	’s	’s	PART
ihlr-21707	26	5	rising	rise	VERB
ihlr-21707	26	6	cost	cost	NOUN
ihlr-21707	26	7	–	–	PUNCT
ihlr-21707	26	8	and	and	CCONJ
ihlr-21707	26	9	the	the	DET
ihlr-21707	26	10	need	need	NOUN
ihlr-21707	26	11	for	for	ADP
ihlr-21707	26	12	reform	reform	NOUN
ihlr-21707	26	13	the	the	DET
ihlr-21707	26	14	facts	fact	NOUN
ihlr-21707	26	15	on	on	ADP
ihlr-21707	26	16	medicare	medicare	PROPN
ihlr-21707	26	17	and	and	CCONJ
ihlr-21707	26	18	health	health	NOUN
ihlr-21707	26	19	spending	spending	NOUN
ihlr-21707	26	20	and	and	CCONJ
ihlr-21707	26	21	financing	financing	NOUN
ihlr-21707	26	22	cms	cms	NOUN
ihlr-21707	26	23	releases	release	VERB
ihlr-21707	26	24	prescriber	prescriber	NOUN
ihlr-21707	26	25	data	datum	NOUN
ihlr-21707	26	26	for	for	ADP
ihlr-21707	26	27	the	the	DET
ihlr-21707	26	28	first	first	ADJ
ihlr-21707	26	29	time	time	NOUN
ihlr-21707	26	30	how	how	SCONJ
ihlr-21707	26	31	is	be	AUX
ihlr-21707	26	32	medicare	medicare	PROPN
ihlr-21707	26	33	funded	fund	VERB
ihlr-21707	26	34	?	?	PUNCT
ihlr-21707	27	1	supra	supra	PROPN
ihlr-21707	27	2	supra	supra	PROPN
ihlr-21707	28	1	i	i	PRON
ihlr-21707	28	2	d.	d.	PROPN
ihlr-21707	29	1	i	i	PRON
ihlr-21707	29	2	d.	d.	PROPN
ihlr-21707	29	3	fewer	few	ADJ
ihlr-21707	29	4	employers	employer	NOUN
ihlr-21707	29	5	to	to	PART
ihlr-21707	29	6	offer	offer	VERB
ihlr-21707	29	7	retiree	retiree	NOUN
ihlr-21707	29	8	prescription	prescription	NOUN
ihlr-21707	29	9	drug	drug	NOUN
ihlr-21707	29	10	plans	plan	NOUN
ihlr-21707	29	11	:	:	PUNCT
ihlr-21707	29	12	survey	survey	NOUN
ihlr-21707	29	13	.	.	PUNCT
ihlr-21707	30	1	i	i	PRON
ihlr-21707	30	2	d.	d.	PROPN
ihlr-21707	31	1	i	i	PRON
ihlr-21707	31	2	d.	d.	PROPN
ihlr-21707	32	1	i	i	PROPN
ihlr-21707	32	2	d.	d.	PROPN
ihlr-21707	32	3	supra	supra	PROPN
ihlr-21707	32	4	a.	a.	PROPN
ihlr-21707	32	5	off	off	ADP
ihlr-21707	32	6	-	-	PUNCT
ihlr-21707	32	7	label	label	NOUN
ihlr-21707	32	8	prescription	prescription	NOUN
ihlr-21707	32	9	drug	drug	NOUN
ihlr-21707	32	10	use	use	NOUN
ihlr-21707	32	11	i	i	PRON
ihlr-21707	33	1	d.	d.	PROPN
ihlr-21707	34	1	i	i	PROPN
ihlr-21707	34	2	d.	d.	PROPN
ihlr-21707	34	3	supra	supra	PROPN
ihlr-21707	34	4	off	off	ADP
ihlr-21707	34	5	-	-	PUNCT
ihlr-21707	34	6	label	label	NOUN
ihlr-21707	34	7	use	use	NOUN
ihlr-21707	34	8	,	,	PUNCT
ihlr-21707	34	9	prescription	prescription	NOUN
ihlr-21707	34	10	,	,	PUNCT
ihlr-21707	34	11	and	and	CCONJ
ihlr-21707	34	12	marketing	marketing	NOUN
ihlr-21707	34	13	of	of	ADP
ihlr-21707	34	14	fda	fda	PROPN
ihlr-21707	34	15	-	-	PUNCT
ihlr-21707	34	16	approved	approve	VERB
ihlr-21707	34	17	drugs	drug	NOUN
ihlr-21707	34	18	:	:	PUNCT
ihlr-21707	34	19	an	an	DET
ihlr-21707	34	20	assessment	assessment	NOUN
ihlr-21707	34	21	of	of	ADP
ihlr-21707	34	22	legislative	legislative	ADJ
ihlr-21707	34	23	and	and	CCONJ
ihlr-21707	34	24	regulatory	regulatory	ADJ
ihlr-21707	34	25	policy	policy	NOUN
ihlr-21707	34	26	see	see	VERB
ihlr-21707	34	27	also	also	ADV
ihlr-21707	34	28	liability	liability	NOUN
ihlr-21707	34	29	and	and	CCONJ
ihlr-21707	34	30	off	off	ADP
ihlr-21707	34	31	-	-	PUNCT
ihlr-21707	34	32	label	label	NOUN
ihlr-21707	34	33	prescriptions	prescription	NOUN
ihlr-21707	34	34	i	i	PRON
ihlr-21707	34	35	d.	d.	VERB
ihlr-21707	34	36	off	off	ADP
ihlr-21707	34	37	-	-	PUNCT
ihlr-21707	34	38	label	label	NOUN
ihlr-21707	34	39	drug	drug	NOUN
ihlr-21707	34	40	promotion	promotion	NOUN
ihlr-21707	34	41	and	and	CCONJ
ihlr-21707	34	42	the	the	DET
ihlr-21707	34	43	first	first	ADJ
ihlr-21707	34	44	amendment	amendment	NOUN
ihlr-21707	34	45	off	off	ADP
ihlr-21707	34	46	-	-	PUNCT
ihlr-21707	34	47	label	label	NOUN
ihlr-21707	34	48	use	use	NOUN
ihlr-21707	34	49	promotion	promotion	NOUN
ihlr-21707	34	50	is	be	AUX
ihlr-21707	34	51	protected	protect	VERB
ihlr-21707	35	1	free	free	ADJ
ihlr-21707	35	2	speech	speech	NOUN
ihlr-21707	35	3	supra	supra	PROPN
ihlr-21707	35	4	b.	b.	PROPN
ihlr-21707	35	5	delaying	delay	VERB
ihlr-21707	35	6	generic	generic	ADJ
ihlr-21707	35	7	entry	entry	NOUN
ihlr-21707	36	1	i	i	PRON
ihlr-21707	36	2	d.	d.	PROPN
ihlr-21707	36	3	off	off	ADP
ihlr-21707	36	4	-	-	PUNCT
ihlr-21707	36	5	label	label	NOUN
ihlr-21707	36	6	prescribing	prescribing	NOUN
ihlr-21707	36	7	supra	supra	NOUN
ihlr-21707	36	8	i	i	PRON
ihlr-21707	36	9	d.	d.	PROPN
ihlr-21707	36	10	see	see	VERB
ihlr-21707	36	11	i	i	PROPN
ihlr-21707	36	12	d.	d.	PROPN
ihlr-21707	37	1	i	i	PROPN
ihlr-21707	37	2	d.	d.	PROPN
ihlr-21707	37	3	medicines	medicine	NOUN
ihlr-21707	37	4	:	:	PUNCT
ihlr-21707	37	5	cost	cost	NOUN
ihlr-21707	37	6	in	in	ADP
ihlr-21707	37	7	context	context	PROPN
ihlr-21707	37	8	new	new	PROPN
ihlr-21707	37	9	york	york	PROPN
ihlr-21707	37	10	attorney	attorney	PROPN
ihlr-21707	37	11	general	general	NOUN
ihlr-21707	37	12	examining	examine	VERB
ihlr-21707	37	13	whether	whether	SCONJ
ihlr-21707	37	14	turing	ture	VERB
ihlr-21707	37	15	restricted	restricted	ADJ
ihlr-21707	37	16	drug	drug	NOUN
ihlr-21707	37	17	access	access	NOUN
ihlr-21707	37	18	i	i	PRON
ihlr-21707	37	19	d.	d.	PROPN
ihlr-21707	37	20	economic	economic	ADJ
ihlr-21707	37	21	basics	basic	NOUN
ihlr-21707	37	22	:	:	PUNCT
ihlr-21707	37	23	supply	supply	NOUN
ihlr-21707	37	24	and	and	CCONJ
ihlr-21707	37	25	demand	demand	NOUN
ihlr-21707	37	26	supra	supra	PROPN
ihlr-21707	37	27	.	.	PUNCT
ihlr-21707	38	1	i	i	PRON
ihlr-21707	38	2	d.	d.	PROPN
ihlr-21707	38	3	actavis	actavis	PROPN
ihlr-21707	38	4	typically	typically	ADV
ihlr-21707	38	5	i	i	PRON
ihlr-21707	38	6	d.	d.	PROPN
ihlr-21707	38	7	see	see	VERB
ihlr-21707	38	8	,	,	PUNCT
ihlr-21707	38	9	e.g.	e.g.	ADV
ihlr-21707	38	10	supra	supra	PROPN
ihlr-21707	38	11	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	38	12	antitrust	antitrust	NOUN
ihlr-21707	38	13	:	:	PUNCT
ihlr-21707	38	14	delayed	delay	VERB
ihlr-21707	38	15	generic	generic	ADJ
ihlr-21707	38	16	entry	entry	NOUN
ihlr-21707	38	17	cases	case	NOUN
ihlr-21707	38	18	i	i	PRON
ihlr-21707	38	19	d.	d.	PROPN
ihlr-21707	38	20	supra	supra	PROPN
ihlr-21707	38	21	see	see	VERB
ihlr-21707	38	22	generally	generally	ADV
ihlr-21707	38	23	abuse	abuse	NOUN
ihlr-21707	38	24	of	of	ADP
ihlr-21707	38	25	the	the	DET
ihlr-21707	38	26	fda	fda	PROPN
ihlr-21707	38	27	citizen	citizen	PROPN
ihlr-21707	38	28	petition	petition	NOUN
ihlr-21707	38	29	process	process	NOUN
ihlr-21707	38	30	:	:	PUNCT
ihlr-21707	38	31	ripe	ripe	ADJ
ihlr-21707	38	32	for	for	ADP
ihlr-21707	38	33	antitrust	antitrust	ADJ
ihlr-21707	38	34	challenge	challenge	NOUN
ihlr-21707	38	35	?	?	PUNCT
ihlr-21707	39	1	i	i	PRON
ihlr-21707	39	2	d.	d.	PROPN
ihlr-21707	39	3	ftc	ftc	PROPN
ihlr-21707	39	4	files	files	PROPN
ihlr-21707	39	5	amicus	amicus	PROPN
ihlr-21707	39	6	brief	brief	NOUN
ihlr-21707	39	7	explaining	explain	VERB
ihlr-21707	39	8	that	that	SCONJ
ihlr-21707	39	9	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	39	10	“	"	PUNCT
ihlr-21707	39	11	product	product	NOUN
ihlr-21707	39	12	hopping	hopping	NOUN
ihlr-21707	39	13	”	"	PUNCT
ihlr-21707	39	14	can	can	AUX
ihlr-21707	39	15	violate	violate	VERB
ihlr-21707	39	16	the	the	DET
ihlr-21707	39	17	antitrust	antitrust	ADJ
ihlr-21707	39	18	laws	law	NOUN
ihlr-21707	39	19	i	i	PRON
ihlr-21707	39	20	d.	d.	PROPN
ihlr-21707	39	21	antitrust	antitrust	ADJ
ihlr-21707	39	22	scrutiny	scrutiny	NOUN
ihlr-21707	39	23	of	of	ADP
ihlr-21707	39	24	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	39	25	“	"	PUNCT
ihlr-21707	39	26	product	product	NOUN
ihlr-21707	39	27	hopping	hop	VERB
ihlr-21707	39	28	”	"	PUNCT
ihlr-21707	39	29	i	i	PROPN
ihlr-21707	39	30	d.	d.	PROPN
ihlr-21707	39	31	venture	venture	PROPN
ihlr-21707	39	32	capital	capital	PROPN
ihlr-21707	39	33	philanthropy	philanthropy	NOUN
ihlr-21707	39	34	:	:	PUNCT
ihlr-21707	39	35	the	the	DET
ihlr-21707	39	36	irs	irs	PROPN
ihlr-21707	39	37	and	and	CCONJ
ihlr-21707	39	38	treasury	treasury	PROPN
ihlr-21707	39	39	hold	hold	VERB
ihlr-21707	39	40	the	the	DET
ihlr-21707	39	41	no	no	DET
ihlr-21707	39	42	-	-	PUNCT
ihlr-21707	39	43	cost	cost	NOUN
ihlr-21707	39	44	key	key	NOUN
ihlr-21707	39	45	to	to	ADP
ihlr-21707	39	46	the	the	DET
ihlr-21707	39	47	growth	growth	NOUN
ihlr-21707	39	48	of	of	ADP
ihlr-21707	39	49	self	self	NOUN
ihlr-21707	39	50	-	-	PUNCT
ihlr-21707	39	51	sufficient	sufficient	ADJ
ihlr-21707	39	52	nonprofits	nonprofit	NOUN
ihlr-21707	39	53	january	january	PROPN
ihlr-21707	39	54	2002	2002	NUM
ihlr-21707	40	1	i	i	PRON
ihlr-21707	40	2	d.	d.	PROPN
ihlr-21707	40	3	supra	supra	PROPN
ihlr-21707	40	4	see	see	VERB
ihlr-21707	40	5	generally	generally	ADV
ihlr-21707	40	6	the	the	DET
ihlr-21707	40	7	emergence	emergence	NOUN
ihlr-21707	40	8	of	of	ADP
ihlr-21707	40	9	‘	'	PUNCT
ihlr-21707	40	10	venture	venture	NOUN
ihlr-21707	40	11	philanthropy	philanthropy	NOUN
ihlr-21707	40	12	’	'	PUNCT
ihlr-21707	40	13	raises	raise	VERB
ihlr-21707	40	14	new	new	ADJ
ihlr-21707	40	15	tax	tax	NOUN
ihlr-21707	40	16	issues	issue	NOUN
ihlr-21707	40	17	see	see	VERB
ihlr-21707	40	18	also	also	ADV
ihlr-21707	40	19	foundation	foundation	NOUN
ihlr-21707	40	20	grants	grant	NOUN
ihlr-21707	40	21	supra	supra	PROPN
ihlr-21707	40	22	venture	venture	PROPN
ihlr-21707	40	23	philanthropy	philanthropy	NOUN
ihlr-21707	40	24	:	:	PUNCT
ihlr-21707	40	25	the	the	DET
ihlr-21707	40	26	changing	change	VERB
ihlr-21707	40	27	landscape	landscape	NOUN
ihlr-21707	40	28	‘	'	PUNCT
ihlr-21707	40	29	venture	venture	NOUN
ihlr-21707	40	30	philanthropy	philanthropy	NOUN
ihlr-21707	40	31	’	'	PUNCT
ihlr-21707	40	32	is	be	AUX
ihlr-21707	40	33	the	the	DET
ihlr-21707	40	34	new	new	ADJ
ihlr-21707	40	35	buzz	buzz	NOUN
ihlr-21707	40	36	in	in	ADP
ihlr-21707	40	37	business	business	NOUN
ihlr-21707	40	38	who	who	PRON
ihlr-21707	40	39	’s	’	VERB
ihlr-21707	40	40	afraid	afraid	ADJ
ihlr-21707	40	41	of	of	ADP
ihlr-21707	40	42	philanthrocapitalism	philanthrocapitalism	NOUN
ihlr-21707	40	43	?	?	PUNCT
ihlr-21707	40	44	,	,	PUNCT
ihlr-21707	40	45	the	the	DET
ihlr-21707	40	46	private	private	ADJ
ihlr-21707	40	47	foundation	foundation	NOUN
ihlr-21707	40	48	i	i	PRON
ihlr-21707	40	49	d.	d.	PROPN
ihlr-21707	41	1	i	i	PRON
ihlr-21707	41	2	d.	d.	PROPN
ihlr-21707	41	3	see	see	AUX
ihlr-21707	41	4	see	see	VERB
ihlr-21707	41	5	a.	a.	NOUN
ihlr-21707	41	6	potential	potential	ADJ
ihlr-21707	41	7	abuses	abuse	NOUN
ihlr-21707	41	8	see	see	VERB
ihlr-21707	41	9	cystic	cystic	ADJ
ihlr-21707	41	10	fibrosis	fibrosis	NOUN
ihlr-21707	41	11	:	:	PUNCT
ihlr-21707	41	12	charity	charity	NOUN
ihlr-21707	41	13	and	and	CCONJ
ihlr-21707	41	14	industry	industry	NOUN
ihlr-21707	41	15	partner	partner	NOUN
ihlr-21707	41	16	for	for	ADP
ihlr-21707	41	17	profit	profit	NOUN
ihlr-21707	41	18	supra	supra	PROPN
ihlr-21707	41	19	see	see	VERB
ihlr-21707	41	20	also	also	ADV
ihlr-21707	41	21	the	the	DET
ihlr-21707	41	22	private	private	ADJ
ihlr-21707	41	23	foundation	foundation	NOUN
ihlr-21707	41	24	supra	supra	PROPN
ihlr-21707	41	25	the	the	DET
ihlr-21707	41	26	private	private	ADJ
ihlr-21707	41	27	foundation	foundation	PROPN
ihlr-21707	41	28	supra	supra	PROPN
ihlr-21707	41	29	loans	loan	NOUN
ihlr-21707	41	30	see	see	AUX
ihlr-21707	41	31	also	also	ADV
ihlr-21707	41	32	see	see	VERB
ihlr-21707	41	33	generally	generally	ADV
ihlr-21707	41	34	supra	supra	ADJ
ihlr-21707	41	35	finding	find	VERB
ihlr-21707	41	36	a	a	DET
ihlr-21707	41	37	cure	cure	NOUN
ihlr-21707	41	38	:	:	PUNCT
ihlr-21707	41	39	incentivizing	incentivize	VERB
ihlr-21707	41	40	partnerships	partnership	NOUN
ihlr-21707	41	41	between	between	ADP
ihlr-21707	41	42	disease	disease	NOUN
ihlr-21707	41	43	advocacy	advocacy	NOUN
ihlr-21707	41	44	groups	group	NOUN
ihlr-21707	41	45	and	and	CCONJ
ihlr-21707	41	46	academic	academic	ADJ
ihlr-21707	41	47	and	and	CCONJ
ihlr-21707	41	48	commercial	commercial	ADJ
ihlr-21707	41	49	researchers	researcher	NOUN
ihlr-21707	41	50	see	see	VERB
ihlr-21707	41	51	the	the	DET
ihlr-21707	41	52	role	role	NOUN
ihlr-21707	41	53	of	of	ADP
ihlr-21707	41	54	nonprofit	nonprofit	ADJ
ihlr-21707	41	55	institutes	institute	NOUN
ihlr-21707	41	56	in	in	ADP
ihlr-21707	41	57	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	41	58	development	development	NOUN
ihlr-21707	41	59	advanced	advanced	ADJ
ihlr-21707	41	60	r&d	r&d	NOUN
ihlr-21707	41	61	by	by	ADP
ihlr-21707	41	62	venture	venture	NOUN
ihlr-21707	41	63	philanthropy	philanthropy	NOUN
ihlr-21707	41	64	1	1	NUM
ihlr-21707	41	65	.	.	PUNCT
ihlr-21707	41	66	pharmaceutical	pharmaceutical	NOUN
ihlr-21707	41	67	companies	company	NOUN
ihlr-21707	41	68	creating	create	VERB
ihlr-21707	41	69	their	their	PRON
ihlr-21707	41	70	own	own	ADJ
ihlr-21707	41	71	philanthropies	philanthropy	NOUN
ihlr-21707	41	72	then	then	ADV
ihlr-21707	41	73	funding	fund	VERB
ihlr-21707	41	74	them	they	PRON
ihlr-21707	41	75	2	2	NUM
ihlr-21707	41	76	.	.	PUNCT
ihlr-21707	41	77	limiting	limit	VERB
ihlr-21707	41	78	the	the	DET
ihlr-21707	41	79	field	field	NOUN
ihlr-21707	41	80	of	of	ADP
ihlr-21707	41	81	ideas	idea	NOUN
ihlr-21707	41	82	to	to	ADP
ihlr-21707	41	83	the	the	DET
ihlr-21707	41	84	ideas	idea	NOUN
ihlr-21707	41	85	heavily	heavily	ADV
ihlr-21707	41	86	funded	fund	VERB
ihlr-21707	41	87	by	by	ADP
ihlr-21707	41	88	corporations	corporation	NOUN
ihlr-21707	41	89	stop	stop	VERB
ihlr-21707	41	90	subsidizing	subsidize	VERB
ihlr-21707	41	91	big	big	ADJ
ihlr-21707	41	92	pharma	pharma	NOUN
ihlr-21707	41	93	i	i	PRON
ihlr-21707	41	94	d.	d.	PROPN
ihlr-21707	41	95	see	see	VERB
ihlr-21707	41	96	establishing	establish	VERB
ihlr-21707	41	97	a	a	DET
ihlr-21707	41	98	nonprofit	nonprofit	ADJ
ihlr-21707	41	99	organization	organization	NOUN
ihlr-21707	41	100	walkthrough	walkthrough	VERB
ihlr-21707	41	101	the	the	DET
ihlr-21707	41	102	private	private	ADJ
ihlr-21707	41	103	foundation	foundation	NOUN
ihlr-21707	41	104	supra	supra	PROPN
ihlr-21707	41	105	i	i	PRON
ihlr-21707	41	106	d.	d.	PROPN
ihlr-21707	41	107	supra	supra	PROPN
ihlr-21707	42	1	i	i	PROPN
ihlr-21707	42	2	d.	d.	PROPN
ihlr-21707	42	3	supra	supra	PROPN
ihlr-21707	43	1	i	i	PROPN
ihlr-21707	43	2	d.	d.	PROPN
ihlr-21707	43	3	b.	b.	PROPN
ihlr-21707	43	4	potential	potential	ADJ
ihlr-21707	43	5	benefits	benefit	NOUN
ihlr-21707	43	6	and	and	CCONJ
ihlr-21707	43	7	increase	increase	VERB
ihlr-21707	43	8	innovation	innovation	NOUN
ihlr-21707	43	9	through	through	ADP
ihlr-21707	43	10	nonprofit	nonprofit	ADJ
ihlr-21707	43	11	funding	funding	NOUN
ihlr-21707	43	12	of	of	ADP
ihlr-21707	43	13	research	research	NOUN
ihlr-21707	43	14	and	and	CCONJ
ihlr-21707	43	15	development	development	NOUN
ihlr-21707	44	1	i	i	PROPN
ihlr-21707	44	2	d.	d.	PROPN
ihlr-21707	45	1	i	i	PRON
ihlr-21707	45	2	d.	d.	PROPN
ihlr-21707	45	3	i	i	PRON
ihlr-21707	45	4	d.	d.	PROPN
ihlr-21707	46	1	i	i	PROPN
ihlr-21707	46	2	d	d	PROPN
ihlr-21707	47	1	i	i	PRON
ihlr-21707	47	2	d.	d.	PROPN
ihlr-21707	47	3	see	see	VERB
ihlr-21707	47	4	generally	generally	ADV
ihlr-21707	47	5	i	i	PRON
ihlr-21707	47	6	d.	d.	PROPN
ihlr-21707	47	7	see	see	VERB
ihlr-21707	47	8	generally	generally	ADV
ihlr-21707	47	9	supra	supra	PROPN
ihlr-21707	47	10	see	see	VERB
ihlr-21707	47	11	generally	generally	ADV
ihlr-21707	47	12	companies	company	NOUN
ihlr-21707	47	13	in	in	ADP
ihlr-21707	47	14	north	north	PROPN
ihlr-21707	47	15	america	america	PROPN
ihlr-21707	47	16	see	see	VERB
ihlr-21707	47	17	supra	supra	PROPN
ihlr-21707	47	18	nonprofit	nonprofit	ADJ
ihlr-21707	47	19	drug	drug	NOUN
ihlr-21707	47	20	companies	company	NOUN
ihlr-21707	47	21	http://doi.org/10.1377/hlthaff.24.6.1684	http://doi.org/10.1377/hlthaff.24.6.1684	NOUN
ihlr-21707	47	22	2	2	X
ihlr-21707	47	23	.	.	PUNCT
ihlr-21707	47	24	economic	economic	ADJ
ihlr-21707	47	25	repurposing	repurposing	NOUN
ihlr-21707	47	26	of	of	ADP
ihlr-21707	47	27	drugs	drug	NOUN
ihlr-21707	47	28	i	i	PRON
ihlr-21707	47	29	d.	d.	PROPN
ihlr-21707	47	30	see	see	VERB
ihlr-21707	47	31	generally	generally	ADV
ihlr-21707	47	32	supra	supra	PROPN
ihlr-21707	47	33	supra	supra	PROPN
ihlr-21707	47	34	see	see	VERB
ihlr-21707	47	35	generally	generally	ADV
ihlr-21707	47	36	the	the	DET
ihlr-21707	47	37	cost	cost	NOUN
ihlr-21707	47	38	of	of	ADP
ihlr-21707	47	39	creating	create	VERB
ihlr-21707	47	40	a	a	DET
ihlr-21707	47	41	new	new	ADJ
ihlr-21707	47	42	drug	drug	NOUN
ihlr-21707	47	43	now	now	ADV
ihlr-21707	47	44	$	$	SYM
ihlr-21707	47	45	5	5	NUM
ihlr-21707	47	46	billion	billion	NUM
ihlr-21707	47	47	,	,	PUNCT
ihlr-21707	47	48	pushing	push	VERB
ihlr-21707	47	49	big	big	ADJ
ihlr-21707	47	50	pharma	pharma	NOUN
ihlr-21707	47	51	to	to	PART
ihlr-21707	47	52	change	change	VERB
ihlr-21707	47	53	supra	supra	PROPN
ihlr-21707	47	54	see	see	VERB
ihlr-21707	47	55	generally	generally	ADV
ihlr-21707	47	56	definition	definition	NOUN
ihlr-21707	47	57	of	of	ADP
ihlr-21707	47	58	a	a	DET
ihlr-21707	47	59	private	private	ADJ
ihlr-21707	47	60	operating	operating	NOUN
ihlr-21707	47	61	foundation	foundation	NOUN
ihlr-21707	47	62	supra	supra	PROPN
ihlr-21707	48	1	i	i	PRON
ihlr-21707	48	2	d.	d.	PROPN
ihlr-21707	49	1	i	i	PRON
ihlr-21707	49	2	d.	d.	PROPN
ihlr-21707	49	3	see	see	VERB
ihlr-21707	49	4	generally	generally	ADV
ihlr-21707	49	5	supra	supra	PROPN
ihlr-21707	49	6	supra	supra	PROPN
ihlr-21707	49	7	c.	c.	PROPN
ihlr-21707	49	8	example	example	PROPN
ihlr-21707	49	9	:	:	PUNCT
ihlr-21707	49	10	cystic	cystic	ADJ
ihlr-21707	49	11	fibrosis	fibrosis	NOUN
ihlr-21707	49	12	foundation	foundation	NOUN
ihlr-21707	49	13	collaboration	collaboration	NOUN
ihlr-21707	49	14	with	with	ADP
ihlr-21707	49	15	vertex	vertex	NOUN
ihlr-21707	49	16	pharmaceuticals	pharmaceutical	NOUN
ihlr-21707	49	17	phrma	phrma	NOUN
ihlr-21707	49	18	statement	statement	NOUN
ihlr-21707	49	19	on	on	ADP
ihlr-21707	49	20	healthcare	healthcare	PROPN
ihlr-21707	49	21	reform	reform	PROPN
ihlr-21707	49	22	coalition	coalition	NOUN
ihlr-21707	49	23	i	i	PROPN
ihlr-21707	49	24	d.	d.	PROPN
ihlr-21707	49	25	supra	supra	PROPN
ihlr-21707	49	26	repurposing	repurpose	VERB
ihlr-21707	49	27	drugs	drug	NOUN
ihlr-21707	49	28	patent	patent	NOUN
ihlr-21707	49	29	tips	tip	NOUN
ihlr-21707	49	30	for	for	ADP
ihlr-21707	49	31	small	small	ADJ
ihlr-21707	49	32	pharma	pharma	NOUN
ihlr-21707	49	33	companies	company	NOUN
ihlr-21707	49	34	repurposing	repurpose	VERB
ihlr-21707	49	35	–	–	PUNCT
ihlr-21707	49	36	finding	find	VERB
ihlr-21707	49	37	new	new	ADJ
ihlr-21707	49	38	uses	use	NOUN
ihlr-21707	49	39	for	for	ADP
ihlr-21707	49	40	old	old	ADJ
ihlr-21707	49	41	(	(	PUNCT
ihlr-21707	49	42	and	and	CCONJ
ihlr-21707	49	43	patented	patented	ADJ
ihlr-21707	49	44	)	)	PUNCT
ihlr-21707	49	45	drugs	drug	NOUN
ihlr-21707	49	46	:	:	PUNCT
ihlr-21707	49	47	bridging	bridge	VERB
ihlr-21707	49	48	the	the	DET
ihlr-21707	49	49	“	"	PUNCT
ihlr-21707	49	50	valley	valley	NOUN
ihlr-21707	49	51	of	of	ADP
ihlr-21707	49	52	death	death	NOUN
ihlr-21707	49	53	,	,	PUNCT
ihlr-21707	49	54	”	"	PUNCT
ihlr-21707	49	55	to	to	PART
ihlr-21707	49	56	translate	translate	VERB
ihlr-21707	49	57	academic	academic	ADJ
ihlr-21707	49	58	research	research	NOUN
ihlr-21707	49	59	into	into	ADP
ihlr-21707	49	60	new	new	ADJ
ihlr-21707	49	61	medicine	medicine	NOUN
ihlr-21707	49	62	supra	supra	PROPN
ihlr-21707	49	63	orphan	orphan	NOUN
ihlr-21707	49	64	products	product	NOUN
ihlr-21707	49	65	:	:	PUNCT
ihlr-21707	49	66	hope	hope	NOUN
ihlr-21707	49	67	for	for	ADP
ihlr-21707	49	68	people	people	NOUN
ihlr-21707	49	69	with	with	ADP
ihlr-21707	49	70	rare	rare	ADJ
ihlr-21707	49	71	diseases	disease	NOUN
ihlr-21707	49	72	see	see	VERB
ihlr-21707	49	73	also	also	ADV
ihlr-21707	49	74	supra	supra	PROPN
ihlr-21707	49	75	a.	a.	PROPN
ihlr-21707	49	76	federal	federal	PROPN
ihlr-21707	49	77	tax	tax	PROPN
ihlr-21707	49	78	re	re	NOUN
ihlr-21707	49	79	-	-	NOUN
ihlr-21707	49	80	evaluation	evaluation	NOUN
ihlr-21707	49	81	for	for	ADP
ihlr-21707	49	82	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	49	83	representatives	representative	NOUN
ihlr-21707	49	84	supra	supra	PROPN
ihlr-21707	50	1	i	i	PRON
ihlr-21707	50	2	d.	d.	PROPN
ihlr-21707	51	1	i	i	PRON
ihlr-21707	51	2	d.	d.	PROPN
ihlr-21707	51	3	i	i	PROPN
ihlr-21707	51	4	d.	d.	PROPN
ihlr-21707	51	5	kalydeco	kalydeco	PROPN
ihlr-21707	51	6	:	:	PUNCT
ihlr-21707	51	7	a	a	DET
ihlr-21707	51	8	price	price	NOUN
ihlr-21707	51	9	too	too	ADV
ihlr-21707	51	10	high	high	ADJ
ihlr-21707	51	11	to	to	PART
ihlr-21707	51	12	pay	pay	VERB
ihlr-21707	51	13	see	see	VERB
ihlr-21707	52	1	i	i	PRON
ihlr-21707	52	2	d.	d.	PROPN
ihlr-21707	52	3	see	see	VERB
ihlr-21707	52	4	supra	supra	PROPN
ihlr-21707	52	5	supra	supra	PROPN
ihlr-21707	52	6	see	see	VERB
ihlr-21707	52	7	supra	supra	PROPN
ihlr-21707	53	1	i	i	PRON
ihlr-21707	53	2	d.	d.	PROPN
ihlr-21707	53	3	i	i	PROPN
ihlr-21707	53	4	d.	d.	PROPN
ihlr-21707	53	5	dep’t	dep’t	PROPN
ihlr-21707	53	6	of	of	ADP
ihlr-21707	53	7	the	the	DET
ihlr-21707	53	8	treasury	treasury	NOUN
ihlr-21707	53	9	,	,	PUNCT
ihlr-21707	53	10	cat	cat	NOUN
ihlr-21707	53	11	.	.	PUNCT
ihlr-21707	54	1	no	no	INTJ
ihlr-21707	54	2	.	.	NOUN
ihlr-21707	55	1	11081l	11081l	NOUN
ihlr-21707	55	2	,	,	PUNCT
ihlr-21707	55	3	travel	travel	NOUN
ihlr-21707	55	4	,	,	PUNCT
ihlr-21707	55	5	entertainment	entertainment	NOUN
ihlr-21707	55	6	,	,	PUNCT
ihlr-21707	55	7	gift	gift	NOUN
ihlr-21707	55	8	,	,	PUNCT
ihlr-21707	55	9	and	and	CCONJ
ihlr-21707	55	10	car	car	NOUN
ihlr-21707	55	11	expenses	expense	NOUN
ihlr-21707	55	12	see	see	VERB
ihlr-21707	55	13	physician	physician	NOUN
ihlr-21707	55	14	payment	payment	NOUN
ihlr-21707	55	15	sunshine	sunshine	NOUN
ihlr-21707	55	16	:	:	PUNCT
ihlr-21707	55	17	some	some	DET
ihlr-21707	55	18	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	55	19	companies	company	NOUN
ihlr-21707	55	20	reduced	reduce	VERB
ihlr-21707	55	21	meal	meal	NOUN
ihlr-21707	55	22	payments	payment	NOUN
ihlr-21707	55	23	to	to	ADP
ihlr-21707	55	24	health	health	NOUN
ihlr-21707	55	25	care	care	NOUN
ihlr-21707	55	26	providers	provider	NOUN
ihlr-21707	55	27	i	i	PRON
ihlr-21707	55	28	d.	d.	PROPN
ihlr-21707	55	29	1	1	NUM
ihlr-21707	55	30	.	.	PUNCT
ihlr-21707	56	1	why	why	SCONJ
ihlr-21707	56	2	regulate	regulate	VERB
ihlr-21707	56	3	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	56	4	promotion	promotion	NOUN
ihlr-21707	56	5	?	?	PUNCT
ihlr-21707	57	1	b.	b.	NOUN
ihlr-21707	57	2	use	use	NOUN
ihlr-21707	57	3	of	of	ADP
ihlr-21707	57	4	modified	modify	VERB
ihlr-21707	57	5	venture	venture	NOUN
ihlr-21707	57	6	philanthropy	philanthropy	NOUN
ihlr-21707	57	7	1	1	NUM
ihlr-21707	57	8	.	.	PUNCT
ihlr-21707	57	9	utilizing	utilize	VERB
ihlr-21707	57	10	private	private	ADJ
ihlr-21707	57	11	nonprofit	nonprofit	ADJ
ihlr-21707	57	12	foundations	foundation	NOUN
ihlr-21707	57	13	with	with	ADP
ihlr-21707	57	14	“	"	PUNCT
ihlr-21707	57	15	program	program	NOUN
ihlr-21707	57	16	-	-	PUNCT
ihlr-21707	57	17	support	support	NOUN
ihlr-21707	57	18	”	"	PUNCT
ihlr-21707	57	19	grants	grant	NOUN
ihlr-21707	57	20	code	code	NOUN
ihlr-21707	57	21	on	on	ADP
ihlr-21707	57	22	interactions	interaction	NOUN
ihlr-21707	57	23	with	with	ADP
ihlr-21707	57	24	healthcare	healthcare	NOUN
ihlr-21707	57	25	professionals	professional	NOUN
ihlr-21707	58	1	i	i	PROPN
ihlr-21707	58	2	d.	d.	PROPN
ihlr-21707	58	3	i	i	PRON
ihlr-21707	58	4	d.	d.	PROPN
ihlr-21707	58	5	.	.	PUNCT
ihlr-21707	59	1	i	i	PRON
ihlr-21707	59	2	d.	d.	PROPN
ihlr-21707	59	3	regulation	regulation	PROPN
ihlr-21707	59	4	of	of	ADP
ihlr-21707	59	5	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	59	6	promotion	promotion	NOUN
ihlr-21707	59	7	:	:	PUNCT
ihlr-21707	59	8	why	why	SCONJ
ihlr-21707	59	9	does	do	AUX
ihlr-21707	59	10	regulation	regulation	NOUN
ihlr-21707	59	11	matter	matter	NOUN
ihlr-21707	59	12	?	?	PUNCT
ihlr-21707	60	1	i	i	PRON
ihlr-21707	60	2	d.	d.	PROPN
ihlr-21707	60	3	poll	poll	PROPN
ihlr-21707	60	4	:	:	PUNCT
ihlr-21707	60	5	americans	americans	PROPN
ihlr-21707	60	6	’	'	PUNCT
ihlr-21707	60	7	no	no	INTJ
ihlr-21707	60	8	.	.	NOUN
ihlr-21707	60	9	1	1	NUM
ihlr-21707	60	10	health	health	NOUN
ihlr-21707	60	11	priority	priority	NOUN
ihlr-21707	60	12	is	be	AUX
ihlr-21707	60	13	keeping	keep	VERB
ihlr-21707	60	14	critical	critical	ADJ
ihlr-21707	60	15	drugs	drug	NOUN
ihlr-21707	60	16	affordable	affordable	ADJ
ihlr-21707	60	17	for	for	ADP
ihlr-21707	60	18	patients	patient	NOUN
ihlr-21707	60	19	,	,	PUNCT
ihlr-21707	60	20	see	see	VERB
ihlr-21707	60	21	generally	generally	ADV
ihlr-21707	60	22	supra	supra	PROPN
ihlr-21707	60	23	see	see	VERB
ihlr-21707	60	24	generally	generally	ADV
ihlr-21707	60	25	generic	generic	ADJ
ihlr-21707	60	26	brand	brand	NOUN
ihlr-21707	60	27	-	-	PUNCT
ihlr-21707	60	28	name	name	NOUN
ihlr-21707	60	29	see	see	VERB
ihlr-21707	60	30	definition	definition	NOUN
ihlr-21707	60	31	of	of	ADP
ihlr-21707	60	32	a	a	DET
ihlr-21707	60	33	private	private	ADJ
ihlr-21707	60	34	operating	operating	NOUN
ihlr-21707	60	35	foundation	foundation	NOUN
ihlr-21707	60	36	supra	supra	PROPN
ihlr-21707	60	37	taking	take	VERB
ihlr-21707	60	38	you	you	PRON
ihlr-21707	60	39	from	from	ADP
ihlr-21707	60	40	idea	idea	NOUN
ihlr-21707	60	41	to	to	ADP
ihlr-21707	60	42	ind	ind	NOUN
ihlr-21707	60	43	and	and	CCONJ
ihlr-21707	60	44	beyond	beyond	ADP
ihlr-21707	60	45	see	see	VERB
ihlr-21707	60	46	i	i	PROPN
ihlr-21707	60	47	d.	d.	PROPN
ihlr-21707	60	48	supra	supra	PROPN
ihlr-21707	60	49	creating	create	VERB
ihlr-21707	60	50	own	own	ADJ
ihlr-21707	60	51	private	private	ADJ
ihlr-21707	60	52	,	,	PUNCT
ihlr-21707	60	53	operating	operating	NOUN
ihlr-21707	60	54	,	,	PUNCT
ihlr-21707	60	55	foundations	foundation	NOUN
ihlr-21707	60	56	transcelerate	transcelerate	ADJ
ihlr-21707	60	57	biopharma	biopharma	PROPN
ihlr-21707	60	58	,	,	PUNCT
ihlr-21707	60	59	inc	inc	PROPN
ihlr-21707	60	60	.	.	PROPN
ihlr-21707	60	61	,	,	PUNCT
ihlr-21707	60	62	transcelerate	transcelerate	PROPN
ihlr-21707	60	63	biopharma	biopharma	NOUN
ihlr-21707	60	64	the	the	DET
ihlr-21707	60	65	orphan	orphan	NOUN
ihlr-21707	60	66	drug	drug	NOUN
ihlr-21707	60	67	:	:	PUNCT
ihlr-21707	60	68	what	what	PRON
ihlr-21707	60	69	’s	’	VERB
ihlr-21707	60	70	right	right	ADJ
ihlr-21707	60	71	with	with	ADP
ihlr-21707	60	72	it	it	PRON
ihlr-21707	60	73	supra	supra	ADJ
ihlr-21707	60	74	foundations	foundation	NOUN
ihlr-21707	60	75	:	:	PUNCT
ihlr-21707	60	76	overview	overview	VERB
ihlr-21707	60	77	ten	ten	NUM
ihlr-21707	60	78	pharmaceutical	pharmaceutical	ADJ
ihlr-21707	60	79	companies	company	NOUN
ihlr-21707	60	80	unite	unite	VERB
ihlr-21707	60	81	to	to	PART
ihlr-21707	60	82	accelerate	accelerate	VERB
ihlr-21707	60	83	development	development	NOUN
ihlr-21707	60	84	of	of	ADP
ihlr-21707	60	85	new	new	ADJ
ihlr-21707	60	86	medicines	medicine	NOUN
ihlr-21707	60	87	i	i	PRON
ihlr-21707	60	88	d.	d.	PROPN
ihlr-21707	60	89	supra	supra	PROPN
ihlr-21707	60	90	transcelerate	transcelerate	PROPN
ihlr-21707	60	91	“	"	PUNCT
ihlr-21707	60	92	if	if	SCONJ
ihlr-21707	60	93	you	you	PRON
ihlr-21707	60	94	want	want	VERB
ihlr-21707	60	95	to	to	PART
ihlr-21707	60	96	be	be	AUX
ihlr-21707	60	97	incrementally	incrementally	ADV
ihlr-21707	60	98	better	well	ADJ
ihlr-21707	60	99	:	:	PUNCT
ihlr-21707	60	100	be	be	AUX
ihlr-21707	60	101	competitive	competitive	ADJ
ihlr-21707	60	102	.	.	PUNCT
ihlr-21707	61	1	if	if	SCONJ
ihlr-21707	61	2	you	you	PRON
ihlr-21707	61	3	want	want	VERB
ihlr-21707	61	4	to	to	PART
ihlr-21707	61	5	be	be	AUX
ihlr-21707	61	6	exponentially	exponentially	ADV
ihlr-21707	61	7	better	well	ADV
ihlr-21707	61	8	:	:	PUNCT
ihlr-21707	61	9	be	be	AUX
ihlr-21707	61	10	cooperative	cooperative	ADJ
ihlr-21707	61	11	.	.	PUNCT
ihlr-21707	61	12	”	"	PUNCT
ihlr-21707	62	1	private	private	ADJ
ihlr-21707	62	2	foundations	foundation	NOUN